Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-10-30Clinical Trial Update: Study to Explore the Effective Doses and to Assess the Safety and Efficacy of Hypidone Hydrochloride Tablets [Phase 2]
Phase 2 trial assessing effective doses, safety, and efficacy of Hypidone Hydrochloride Tablets for major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2020-10-30Clinical Trial Update: To Explore the Safety and Efficacy of Hypidone Hydrochloride Tablets in Treatment of Patients With MDD [Phase 1, Phase 2]
Clinical trial update for Hypidone Hydrochloride Tablets in major depressive disorder, spanning Phase 1 and Phase 2, status completed.
-
CLINICAL_TRIALS trial_result · 2020-10-29Clinical Trial Update: 54135419SUI3001: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide [Phase 3]
This ClinicalTrials.gov update reports the completion of a Phase 3 study evaluating intranasal esketamine plus standard of care for rapid re…
-
CLINICAL_TRIALS trial_result · 2020-10-28Clinical Trial Update: Intra-nasal vs. Intra-venous Ketamine Administration [Phase 4]
Phase 4 trial comparing intra-nasal versus intra-venous ketamine administration in adults with major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2020-10-23Clinical Trial Update: Study to Treat Major Depressive Disorder With a New Medication [Phase 2]
Phase 2 trial update for a new medication targeting major depressive disorder with symptoms including anhedonia; study completed with posted…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-10-23Clinical Trial Update: Desvenlafaxine in Opioid-Dependent Patients [Phase 4]
Phase 4 trial update involving desvenlafaxine in patients with depression and opioid dependence (including methadone treatment) has complete…
-
CLINICAL_TRIALS trial_result · 2020-10-20Clinical Trial Update: Tocilizumab Augmentation in Treatment-Refractory Major Depressive Disorder [Phase 2]
Phase 2 trial investigating tocilizumab augmentation in treatment-refractory major depressive disorder; study terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression [Phase 2]
Phase 2 study in Japanese participants evaluated fixed-dose intranasal esketamine for treatment-resistant depression; the trial completed an…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Adjunct Minocyline in Treatment-resistant Depression [Phase 2]
Phase 2 clinical trial investigating adjunct minocycline for treatment-resistant major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Anxiety and Depression in Epilepsy: A Treatment Study [Phase 4]
Phase 4 clinical trial examining treatment for anxiety and depression in patients with epilepsy has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Development and Pilot Trial of an Intervention to Reduce Disclosure Recipients Negative Social Reactions and Victims Psychological Distress and Problem Drinking [NA]
A pilot trial evaluating an intervention aimed at reducing negative social reactions to disclosure and associated psychological distress and…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Prevention of Comorbid Depression and Obesity in Attention-deficit/ Hyperactivity Disorder [Phase 2]
Phase 2 trial investigating prevention of comorbid depression and obesity in adults with ADHD; completed.
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients [Phase 2]
Phase 2 trial update for eIMPACT evaluating modernized collaborative care to reduce excess cardiovascular risk in older patients with depres…
-
CLINICAL_TRIALS trial_result · 2020-10-09Clinical Trial Update: Study of Monotherapy Rapastinel in the Prevention of Relapse in Patients With Major Depressive Disorder (MDD) [Phase 3]
Phase 3 trial of rapastinel monotherapy in major depressive disorder was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: IntelliCare in College Students [NA]
A completed clinical trial on IntelliCare for depression and anxiety in college students with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-06Clinical Trial Update: Emotional and Cognitive Control in Late-Onset Depression [Phase 4]
Phase 4 trial update for emotional and cognitive control in late-onset depression completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-29Clinical Trial Update: A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder [Phase 2]
A Phase II study evaluated the safety and efficacy of PDC-1421 capsules in patients with Major Depressive Disorder; the trial is completed w…
-
CLINICAL_TRIALS trial_result · 2020-09-29Clinical Trial Update: The Modular Protocol for Mental Health (MPMH) [Phase 1, Phase 2]
Phase 1 and Phase 2 study of the Modular Protocol for Mental Health (MPMH) completed; investigates treatment approaches for multiple mental …
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: 54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide [Phase 3]
Phase 3 trial evaluating intranasal esketamine added to standard of care for rapid reduction of symptoms in adults with major depressive dis…
-
CLINICAL_TRIALS trial_result · 2020-09-22Clinical Trial Update: IMPAACT 2002: Cognitive Behavioral Therapy and Medication Management for Treatment of Depression in US Youth With HIV [NA]
Trial update for IMPAACT 2002 evaluating cognitive behavioral therapy plus medication management for depression in youth with HIV; study com…
-
CLINICAL_TRIALS trial_result · 2020-09-21Clinical Trial Update: Transcranial Laser Therapy, Continuous and Pulsed Light, for Major Depressive Disorder (ELATED-3) [NA]
Clinical trial update for transcranial laser therapy in major depressive disorder; status completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-09-14Clinical Trial Update: Behavioral Intervention for Low Income Depressed Smokers in Drug Treatment [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a behavioral intervention for low-income individuals with depression who are cigarette smokers and in …
-
CLINICAL_TRIALS trial_result · 2020-09-11Clinical Trial Update: A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity Pilot [NA]
Completed pragmatic trial evaluating a policy-relevant US trauma care system for PTSD and comorbidity; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-09-10Clinical Trial Update: Meditation for Depression and Anxiety Symptoms in Dialysis Patients [Phase 3]
Phase 3 clinical trial evaluating meditation for depression and anxiety symptoms in dialysis patients is completed.
-
CLINICAL_TRIALS trial_result · 2020-09-10Clinical Trial Update: Mobile Phone Based Intervention to Protect Mental Health in Healthcare Workers at Frontline Against COVID19 [Phase 3]
Phase 3 trial evaluating a mobile phone-based intervention to protect mental health in frontline healthcare workers during COVID-19, complet…